F2L



F2L

M1MM1L2LL2G3GG3M4MM4I5II5K6KK6N7NN7S8SS8L9LL9F10FF10G11GG11S12SS12V13VV13E14EE14T15TT15W16WW16P17PP17W18WW18Q19QQ19V20VV20L21LL21

SMILES None
InChIKey None
Sequence MLGMIKNSLFGSVETWPWQVL

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

F2L

M1MM1L2LL2G3GG3M4MM4I5II5K6KK6N7NN7S8SS8L9LL9F10FF10G11GG11S12SS12V13VV13E14EE14T15TT15W16WW16P17PP17W18WW18Q19QQ19V20VV20L21LL21

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.